PAMP
TLSIW icon

Polar Asset Management Partners’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Polar Asset Management Partners’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-259,262
Closed -$430K – 812
2024
Q2 		$430K Sell
259,262
-26,602
-9% -$36.1K 0.01% 433
2024
Q1 		$286K Hold
285,864
– – ﹤0.01% 480
2023
Q4 		$340K Hold
285,864
– – 0.01% 479
2023
Q3 		$109K Hold
285,864
– – ﹤0.01% 562
2023
Q2 		$12K Hold
285,864
– – ﹤0.01% 852
2023
Q1 		$17.6K Hold
285,864
– – ﹤0.01% 914
2022
Q4 		$21.4K Hold
285,864
– – ﹤0.01% 992
2022
Q3 		$17K Hold
285,864
– – ﹤0.01% 1187
2022
Q2 		$24K Buy
285,864
+114,494
+67% +$21.9K ﹤0.01% 1164
2022
Q1 		$44K Buy
+171,370
New +$73.7K ﹤0.01% 1012
2021
Q4 		– Sell
-149,840
Closed -$123K – 1510
2021
Q3 		$123K Hold
149,840
– – ﹤0.01% 1068
2021
Q2 		$153K Sell
149,840
-37,459
-20% -$37K ﹤0.01% 975
2021
Q1 		$206K Buy
+187,299
New +$338K ﹤0.01% 778

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Polar Asset Management Partners's TLSIW Position: Q3 2024 in Review

Polar Asset Management Partners sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 259,262 shares — an estimated $430K sold.

Polar Asset Management Partners first reported a position in TLSIW in Q1 2021 and held it in 13 quarters. The position peaked at $430K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Polar Asset Management Partners reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 259,262 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $430K.
  • Polar Asset Management Partners first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 13 quarters.
  • Polar Asset Management Partners's TriSalus Life Sciences Warrant position peaked at $430K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.